Open AccessLong-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa
Author(s) -
Da. Raugi,
Selly Ba,
Ousseynou Cisse,
Kadidiatou Diallo,
Ibrahima Tito Tamba,
Cheikh Tidiane Ndour,
Ndèye Méry Dia Badiane,
Louise Fortes,
Mouhamadou Baïla Diallo,
Dominique Faye,
Robert A. Smith,
Fatima Sall,
Macoumba Touré,
ElHadji Ibrahima Sall,
Habibatou Diallo Agne,
Khadim Faye,
Jean Philippe Diatta,
Marie Pierre Sy,
Ming Chang,
Binetou Diaw,
Jacques F Sambou,
Raphael Bakhoum,
Mame Demba Sy,
A Niang,
Jean Jacques Malomar,
Robert W. Coombs,
Stephen E. Hawes,
Ibra Ndoye,
Nancy B. Kiviat,
Papa Salif Sow,
Moussa Seydi,
Geoffrey S. Gottlieb
Publication year - 2020
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa277
Subject(s) - medicine , viral load , observational study , antiretroviral therapy , cohort , human immunodeficiency virus (hiv) , cohort study , drug resistance , immunology , demography , pediatrics , biology , sociology , microbiology and biotechnology
Programmatic treatment outcome data for people living with human immunodeficiency virus type 2 (HIV-2) in West Africa, where the virus is most prevalent, are scarce.